(Q43826848)

English

Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism

scientific article published on 5 November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism (English)

1 reference

Europe PubMed Central

27 November 2017

0 references

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

author name string

J A Del Campo

1

1 reference

Europe PubMed Central

27 November 2017

J Ampuero

2

1 reference

Europe PubMed Central

27 November 2017

L Rojas

3

1 reference

Europe PubMed Central

27 November 2017

M Conde

4

1 reference

Europe PubMed Central

27 November 2017

A Rojas

5

1 reference

Europe PubMed Central

27 November 2017

M Maraver

6

1 reference

Europe PubMed Central

27 November 2017

R Millán

7

1 reference

Europe PubMed Central

27 November 2017

M García-Valdecasas

8

1 reference

Europe PubMed Central

27 November 2017

J R García-Lozano

9

1 reference

Europe PubMed Central

27 November 2017

M F González-Escribano

10

1 reference

Europe PubMed Central

27 November 2017

M Romero-Gómez

11

1 reference

Europe PubMed Central

27 November 2017

language of work or name

0 references

publication date

5 November 2012

1 reference

Europe PubMed Central

27 November 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

27 November 2017

37

1 reference

Europe PubMed Central

27 November 2017

1

1 reference

Europe PubMed Central

27 November 2017

74-80

1 reference

Europe PubMed Central

27 November 2017

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12113

21 January 2018

Meta-analysis: insulin resistance and sustained virological response in hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12113

21 January 2018

Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12113

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12113

21 January 2018

Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12113

21 January 2018

Boceprevir for untreated chronic HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12113

21 January 2018

Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12113

21 January 2018

Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12113

21 January 2018

Impact of IL28B genotype on the early and sustained virologic response in treatment-naïve patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12113

21 January 2018

Genetic variation of the IL-28B promoter affecting gene expression

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12113

21 January 2018

Insulin resistance and sustained virological response in hepatitis C: from bench to bedside

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12113

21 January 2018

Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12113

21 January 2018

The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12113

21 January 2018

IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12113

21 January 2018

The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12113

21 January 2018

Associations between serum lipids and hepatitis C antiviral treatment efficacy

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12113

21 January 2018

Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12113

21 January 2018

Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12113

21 January 2018

Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naive patients infected with HCV genotype 1.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12113

21 January 2018

Boceprevir for previously treated chronic HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12113

21 January 2018

Identifiers

10.1111/APT.12113

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43826848&oldid=2103693192"